1. "2014"
Formats
  1. Journal Article (2603)
  2. Meeting Abstract (1417)
  3. Book Section (235)
  4. Conference Paper (23)
  5. Book Whole (16)
  6. Review (3)
Groups
  1. Department of Medicine (1584)
  2. GSK Faculty (1082)
  3. Surgery (895)
  4. Solid Tumor Oncology Division (840)
  5. Center for Hematologic Malignancies (703)
  6. Sloan Kettering Institute Faculty (672)

More Groups

People
  1. Jedd Wolchok (71)
  2. Sergio Giralt (71)
  3. Ross Levine (69)
  4. Martin Tallman (62)
  5. Michael Berger (59)
  6. Mithat Gonen (55)

More People

Years
  1. 2014 (4297)
Publications
  1. Journal of Clinical Oncology (420)
  2. Blood (228)
  3. International Journal of Radiation Oncology, Biology, Physics (131)
  4. Cancer Research (104)
  5. Modern Pathology (89)
  6. Laboratory Investigation (82)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (446)
  3. Springer (318)
  4. Elsevier Science, Inc. (246)
  5. Nature Publishing Group (242)
  6. American Society of Hematology (230)

More Publishers

Results (4297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): Early results of US intergroup trial C10403
    Meeting Abstract

    Stock, W.; Luger, S. M.; Advani, A. S.; Geyer, S.; Harvey, R. C.; Mullighan, C. G.; Willman, C. L.; Malnassy, G.; Parker, E.; Laumann, K. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Interim analysis of a phase 1 trial of SGN-CD33A in patients with CD33-positive acute myeloid leukemia (AML)
    Meeting Abstract

    Stein, E. M.; Stein, A.; Walter, R. B.; Fathi, A. T.; Lancet, J. E.; Kovacsovics, T. J.; Advani, A. S.; DeAngelo, D. J.; O'Meara, M. M.; Zhao, B. T.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The DOT1L inhibitor EPZ-5676: Safety and activity in relapsed/refractory patients with MLL-rearranged leukemia
    Meeting Abstract

    Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Savona, M.; Tibes, R.; Altman, J. K.; Jongen-Lavrencic, M.; Döhner, H.; Armstrong, S.; Pollock, R. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • AG-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant metabolic enzyme, induces durable remissions in a phase I study in patients with IDH2 mutation positive advanced hematologic malignancies
    Meeting Abstract

    Stein, E. M.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Fathi, A. T.; Flinn, I.; Frankel, A.; Levine, R. L.; Medeiros, B. C.; Patel, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A phase I study of IMGN529, an antibody-drug conjugate (ADC) targeting CD37, in adult patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Stathis, A.; Freedman, A. S.; Flinn, I. W.; Maddocks, K. J.; Weitman, S.; Berdeja, J. G.; Mejia, A. V.; Zucca, E.; Green, R.; Romanelli, A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Second allogeneic stem cell transplantation for hematologic malignancies using chemotherapy only cytoreduction with clofarabine, melphalan, and thiotepa
    Meeting Abstract

    Spitzer, B.; Perales, M. A.; Kernan, N. A.; Prockop, S. E.; Webb, N.; Castro-Malaspina, H.; Papadopoulos, E. B.; Young, J. W.; Scaradavou, A.; Kobos, R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Characterizing transcriptional and epigenetic signatures induced by FLT3-ITD activation
    Meeting Abstract

    Spitzer, B.; Guryanova, O. A.; Abdel-Wahab, O.; Kucine, N.; Adli, M.; Berman, J. N.; Meshinchi, S.; Bernstein, B.; Pelossof, R.; Leslie, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A systemic xenograft model of Waldenstrom's macroglobulinemia demonstrates the potent anti-tumor effect of second generation CD19 directed chimeric antigen receptor modified T cells in this disease
    Meeting Abstract

    Smith, E. L.; Palomba, M. L.; Park, J. H.; Brentjens, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • Subsequent hematopoietic stem cell transplantation in belinostat-treated patients with relapsed/refractory peripheral T-cell lymphoma (R/R PTCL)
    Meeting Abstract

    Shustov, A. R.; Al-Ali, H. K.; Wulf, G.; Hsu, P.; Choi, M. R.; Allen, L. F.; Visser, O. J.; Zachee, P.; Horwitz, S. M.
    Blood (2014)

    Fulltext@MSK | Save
  • Targeted therapy of B cell lymphoma with a direct inhibitor of the NF-kappa B subunit c-Rel
    Meeting Abstract

    Shono, Y.; Tuckett, A. Z.; Liou, H. C.; Ouk, S.; Doubrovina, E.; Doubrovin, M.; Derenzini, E.; Scallion, M. I.; Tsai, J. J.; Smith, O. M.; more...
    Blood (2014)

    Fulltext@MSK | Save